Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 |
filingDate |
2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2007505071-A |
titleOfInvention |
Crystalline polymorphic nucleoside compounds |
abstract |
The present invention relates to polymorphic crystalline hydrochloride salts of nucleoside barinate esters of formula Ib, methods for treating hepatitis C virus-mediated diseases, and pharmaceutical compositions containing Ib. |
priorityDate |
2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |